SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-050312
Filing Date
2015-06-04
Accepted
2015-06-04 19:27:22
Documents
2
Period of Report
2015-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1495
2 EX-24 DOCUMENT attachment1.htm EX-24 5385
  Complete submission text file 0001209191-15-050312.txt   8521
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142
Business Address
Nicaise Claude (Reporting) CIK: 0001644162 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14895 | Film No.: 15914161